The need for a comprehensive molecular characterization of autism spectrum disorders.
Autism spectrum disorders (ASD) are a heterogeneous group of disorders which have complex behavioural phenotypes. Although ASD is a highly heritable neuropsychiatric disorder, genetic research alone has not provided a profound understanding of the underlying causes. Recent developments using biochemical tools such as transcriptomics, proteomics and cellular models, will pave the way to gain new insights into the underlying pathological pathways. This review addresses the state-of-the-art in the search for molecular biomarkers for ASD. In particular, the most important findings in the biochemical field are highlighted and the need for establishing streamlined interaction between behavioural studies, genetics and proteomics is stressed. Eventually, these approaches will lead to suitable translational ASD models and, therefore, a better disease understanding which may facilitate novel drug discovery efforts in this challenging field.
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Jantine A C
JA
Broek
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Eva
E
Brombacher
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Viktoria
V
Stelzhammer
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Paul C
PC
Guest
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Hassan
H
Rahmoune
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Sabine
S
Bahn
D015415:Biomarkers; D002659:Child Development Disorders, Pervasive / Q000175:diagnosis* / Q000235:genetics; D006801:Humans; D040901:Proteomics
D015415:Biomarkers